Health Trials

Remimazolam NeuroImaging

ConditionsAnesthesiaPainRemimazolam
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-59
SponsorKeith M Vogt

About this trial

This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task

Eligibility criteria

Qualifiers

have none of the specific

Disqualifiers

have a valid email address and valid phone number throughout the study

free from any non-MRI compatible implants

are pregnant or attempting to conceive

body mass index (BMI) > 35

Trial design

Treatments tested in this trial

  • Remimazolam
  • Peripheral Nerve Stimulation

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Keith M Vogt

Lead sponsor

University of Pittsburgh

Sponsor institution

National Institute of General Medical Sciences (NIGMS)

Collaborator

Source ClinicalTrials.gov